Skip to content

13F-HR filed by Two Seas Capital LP

Two Seas Capital LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 13 holding rows worth $457,460,904.

Accession
0001315863-23-000705
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 13 entries on the cover page, a total value of $457,460,904 stated on the cover page (in dollars after the unit check, H1), rows summing to $457,460,904 with VALUE read as dollars as filed, 13F file number 028-22002. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Indivior PLCG4766E116Common Stock13,668,919$325,320,261dollars as filed
ROIVANT SCIENCES LTDG76279101SHS7,909,591$79,728,677dollars as filed
Arbutus Biopharma Corp03879J100Common Shares, without par value8,280,818$19,045,881dollars as filed
META PLATFORMS INC CL A30303M102COM30,003$8,610,261dollars as filed
ODYSSEY MARINE EXPL INC676118201COM NEW1,371,874$4,938,746dollars as filed
ESPERION THERAPEUTICS INC NEW COM29664W105Stock2,941,872$4,089,202dollars as filed
HERTZ GLOBAL HLDGS INC42806J700COM NEW183,909$3,382,087dollars as filed
SONOS INC83570H108COM171,172$2,795,239dollars as filed
ROIVANT SCIENCES LTDG76279119*W EXP 09/30/2021,100,662$2,729,642dollars as filed
OCTAVE SPECIALTY GROUP INC023139884COM NEW187,568$2,670,968dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM232,201$2,212,876dollars as filed
HERTZ GLOBAL HLDGS INC42806J148*W EXP 06/30/205123,494$1,246,054dollars as filed
MALLINCKRODT PLCG5890A102COM585,602$691,010dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-23-000705this filing2023-08-14acceptance time not in the bulk data set